# Clinical Efficacy Analysis of Resveratrol in the Treatment of Primary Ovarian Insufficiency

> **NCT05410093** · NA · UNKNOWN · sponsor: **Affiliated Hospital of Nantong University** · enrollment: 150 (estimated)

## Conditions studied

- Primary Ovarian Insufficiency

## Interventions

- **DRUG:** Resveratrol
- **DRUG:** Vitamin E

## Key facts

- **NCT ID:** NCT05410093
- **Lead sponsor:** Affiliated Hospital of Nantong University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-02-01
- **Primary completion:** 2024-07-31
- **Final completion:** 2024-07-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05410093

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05410093, "Clinical Efficacy Analysis of Resveratrol in the Treatment of Primary Ovarian Insufficiency". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05410093. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*